Search research articles
Contact Us
Filters
Showing results (91-100 of 549) with videos related to
Page
of 55
Sort By:
Endocrinology
|
November 30, 2019
Proglucagon-Derived Peptides, Glucose-Dependent Insulinotropic Polypeptide, and Dipeptidyl Peptidase-4-Mechanisms of Action in Adipose Tissue
Jacqueline L Beaudry, Daniel J Drucker
Annual Review of Nutrition
|
April 11, 2006
Glucagon-like Peptide-2
Jennifer L Estall, Daniel J Drucker
Endocrinology
|
March 27, 2004
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
P L Brubaker, D J Drucker
Physiology (Bethesda, Md.)
|
September 22, 2005
Proglucagon-derived peptides: mechanisms of action and therapeutic potential
Elaine M Sinclair, Daniel J Drucker
Canadian Medical Association Journal
|
January 15, 1985
Pseudotumour cerebri in association with polyarthritis, urticaria and cryoglobulinemia
D J Drucker, A A Bookman
Cell Metabolism
|
May 21, 2013
Pharmacology, physiology, and mechanisms of incretin hormone action
Jonathan E Campbell, Daniel J Drucker
Nature Medicine
|
October 9, 2013
Metabolic disease puts up a fight: are diet and exercise helpful for the heart?
Julie A Lovshin, Daniel J Drucker
Diabetes Care
|
January 31, 2006
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1
Matthew C Riddle, Daniel J Drucker
Circulation Research
|
May 24, 2014
Cardiovascular actions of incretin-based therapies
John R Ussher, Daniel J Drucker
Endocrine Reviews
|
February 11, 2012
Cardiovascular biology of the incretin system
John R Ussher, Daniel J Drucker
Page
of 55
Search research articles
Search
Showing results (91-100 of 549) with videos related to
Sort By:
Page
of 55
Endocrinology
|
November 30, 2019
Proglucagon-Derived Peptides, Glucose-Dependent Insulinotropic Polypeptide, and Dipeptidyl Peptidase-4-Mechanisms of Action in Adipose Tissue
Jacqueline L Beaudry, Daniel J Drucker
Annual Review of Nutrition
|
April 11, 2006
Glucagon-like Peptide-2
Jennifer L Estall, Daniel J Drucker
Endocrinology
|
March 27, 2004
Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system
P L Brubaker, D J Drucker
Physiology (Bethesda, Md.)
|
September 22, 2005
Proglucagon-derived peptides: mechanisms of action and therapeutic potential
Elaine M Sinclair, Daniel J Drucker
Canadian Medical Association Journal
|
January 15, 1985
Pseudotumour cerebri in association with polyarthritis, urticaria and cryoglobulinemia
D J Drucker, A A Bookman
Cell Metabolism
|
May 21, 2013
Pharmacology, physiology, and mechanisms of incretin hormone action
Jonathan E Campbell, Daniel J Drucker
Nature Medicine
|
October 9, 2013
Metabolic disease puts up a fight: are diet and exercise helpful for the heart?
Julie A Lovshin, Daniel J Drucker
Diabetes Care
|
January 31, 2006
Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1
Matthew C Riddle, Daniel J Drucker
Circulation Research
|
May 24, 2014
Cardiovascular actions of incretin-based therapies
John R Ussher, Daniel J Drucker
Endocrine Reviews
|
February 11, 2012
Cardiovascular biology of the incretin system
John R Ussher, Daniel J Drucker
Page
of 55